Efficacy of oral tolvaptan in acute heart failure patients with hypotension and renal impairment
Article 2012 en
Authors
MV
Muthiah Vaduganathan
MG
Mihai Gheorghiade
PP
Peter S. Pang
Abstract
1 min read
In this subgroup analysis of patients with hypotension and renal impairment, tolvaptan improved symptoms, reduced body weight and increased serum sodium as early as inpatient day 1 without adversely affecting blood pressure or renal function.
J. E. A. Blair, Peter S. Pang, Robert W. Schrier, Marco Metra, Brian Traver, Thomas D. Cook, Umberto Campia, Andrew P. Ambrosy, John C. Burnett, L. Grinfeld, Aldo Maggioni, Karl Swedberg, James E. Udelson, Faı̈ez Zannad, Marvin A. Konstam, Mihai Gheorghiade
Eiichi Akiyama, Raphaël Cinotti, Alain Cohen‐Solal, Johan Lassus, Óscar Miró, Aldo Maggioni, Christian Mueller, Jiří Pařenica, J‐C Park, Jindřich Špinar, Y Zhang, Kouichi Tamura, Kazuo Kimura, Étienne Gayat, Alexandre Mebazaa
Discussion(0)
No comments yet. Be the first to comment.